Radionuclide-labelled nanoparticles for cancer combination therapy: a review
Abstract Radionuclide therapy (RT) is widely used to advanced local cancers. However, its therapeutic efficacy is limited to the radiation resistance of cancer cells. Combination therapy aims to circumvent tumor resistance, and the combination of RT with photothermal therapy (PTT), photodynamic ther...
Saved in:
| Main Authors: | Na Sun, Tao Wang, Song Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Journal of Nanobiotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12951-024-03020-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Radionuclide-Labeled Biomaterials: A Novel Strategy for Tumor-Targeted Therapy
by: Shu Zhang, et al.
Published: (2025-06-01) -
Radiosensitization of the Gold, Silver, and Gadolinium Nanoparticles in 177Lu Radionuclide Radiation Field in Microscopic and Macroscopic Scales in the Liver Radionuclide Therapy
by: Wrya Parwaie, et al.
Published: (2025-07-01) -
Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy
by: Solmaz Mojarad-Jabali, et al.
Published: (2025-01-01) -
Estimation of absorbed doses in patients’ organs from the released radionuclide-label during radionuclide therapy with <sup>225</sup>Ac
by: A. E. Petrova, et al.
Published: (2022-04-01) -
Peptide receptor radionuclide therapy for ectopic Cushing’s syndrome caused by metastatic neuroendocrine neoplasms
by: Emma Boehm, et al.
Published: (2024-11-01)